Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Waters to Make DAISO Media Available to Pharmaceutical and Biopharmaceutical Purification Customers MILFORD, Mass. and OSAKA, Japan, Feb. 17 /PRNewswire/ -- Waters Corporation and DAISO CO., LTD...
Vision Publisher Optimizes Workflow and Reduces Compliance Risk with Efficient Data Management MILFORD, Mass., Dec. 15 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE:WAT) today announced that...
Fusion Method Development software Produces More Robust Methods Faster; Method Development Time Reduced from 45-60 Days to 2-3 Days MILFORD, Mass., Dec. 14 /PRNewswire-FirstCall/ -- Waters...
MILFORD, Mass., Dec. 9 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) announced today that it has shipped the first units of its ground-breaking SYNAPT(TM) G2 Mass Spectrometer, first...
UPLC Systems Help Support Agency's Science-Based Efforts to Protect Consumers and Ensure Food is Safe for Consumption MILFORD, Mass., Oct. 20 /PRNewswire-FirstCall/ -- Waters Corporation...
GAO Releases New Report on Food Import Challenges WASHINGTON, Oct. 14 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) today convened the 2nd Annual Global Food Safety Policy Forum with...
Waters MS Systems Handle the Most Complex Applications While Adding Simplicity Throughout the Analytical Workflow MILFORD, Mass., Aug. 27 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE:WAT...
Dedicated UPLC/MS System Solutions Taking on Increased Challenges in Laboratories for Therapeutic Drug Monitoring, Disease Management, Endocrinology, and Toxicology CHICAGO, July 20...
PHILADELPHIA, June 3 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) announced today that the American Society for Mass Spectrometry (ASMS) presented Prof. Alison Ashcroft of the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
